The Annals Take our Readership Survey!
home help contact us subscription past issues search current issue
 QUICK SEARCH:   [advanced]


     


The Annals of Pharmacotherapy: Vol. 34, No. 12, pp. 1478-1482. DOI 10.1345/aph.10031
© 2000 Harvey Whitney Books Company.
This Article
Right arrow PDF
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Articles Ahead of Print
Right arrow [Order Reprint]
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Vaes, L.
Right arrow Articles by Chyka, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Vaes, L.
Right arrow Articles by Chyka, P.


Research Articles

Interactions of warfarin with garlic, ginger, ginkgo, or ginseng: nature of the evidence

LP Vaes and PA Chyka

OBJECTIVE: To review and characterize the evidence describing potential interactions between warfarin and garlic, ginger, ginkgo, or ginseng. DATA SOURCES: Searches of MEDLINE (1966-1999), other bibliographic databases, several abstracting services, and tertiary references were conducted. STUDY SELECTION AND DATA EXTRACTION: Articles were examined by each author, and additional citations were obtained from the references of these articles. Preference was given to Englishlanguage articles of human studies. DATA SYNTHESIS: Evidence is lacking for an interaction of warfarin wth galic or ginger. One case report associates ginseng use with decreased warfarin-maintained anticoagulation effect. Another case report links concomitant use of ginkgo and warfarin with the development of intracerebral hemorrhage. Hemorrhage and tendencies were noted in four cases with ginkgo use and in three cases with garlic; in none of these cases were patients receiving warfarin. CONCLUSIONS: The true risks of these interactions and effects are difficult to characterize due to the limited number and nature of existing reports.


This article has been cited by other articles:


Home page
J Clin PharmacolHome page
X. Jiang, E. Y. L. Blair, and A. J. McLachlan
Investigation of the effects of herbal medicines on warfarin response in healthy subjects: a population pharmacokinetic-pharmacodynamic modeling approach.
J. Clin. Pharmacol., November 1, 2006; 46(11): 1370 - 1378.
[Abstract] [Full Text] [PDF]


Home page
The Annals of PharmacotherapyHome page
L. K Nies, A. A Cymbala, S. L Kasten, D. G Lamprecht, and K. L Olson
Complementary and Alternative Therapies for the Management of Dyslipidemia
Ann. Pharmacother., November 1, 2006; 40(11): 1984 - 1992.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
H. Macan, R. Uykimpang, M. Alconcel, J. Takasu, R. Razon, H. Amagase, and Y. Niihara
Aged Garlic Extract May Be Safe for Patients on Warfarin Therapy
J. Nutr., March 1, 2006; 136(3): 793S - 795S.
[Abstract] [Full Text] [PDF]


Home page
Nutr Clin PractHome page
J. Boullata
Natural Health Product Interactions with Medication
Nutr Clin Pract, February 1, 2005; 20(1): 33 - 51.
[Abstract] [Full Text] [PDF]


Home page
J Clin PharmacolHome page
D. J. Greenblatt and L. L. von Moltke
Interaction of Warfarin With Drugs, Natural Substances, and Foods
J. Clin. Pharmacol., February 1, 2005; 45(2): 127 - 132.
[Abstract] [Full Text] [PDF]


Home page
ANN INTERN MEDHome page
C.-S. Yuan, G. Wei, L. Dey, T. Karrison, L. Nahlik, S. Maleckar, K. Kasza, M. Ang-Lee, and J. Moss
Brief Communication: American Ginseng Reduces Warfarin's Effect in Healthy Patients: A Randomized, Controlled Trial
Ann Intern Med, July 6, 2004; 141(1): 23 - 27.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
A. Sparreboom, M. C. Cox, M. R. Acharya, and W. D. Figg
Herbal Remedies in the United States: Potential Adverse Interactions With Anticancer Agents
J. Clin. Oncol., June 15, 2004; 22(12): 2489 - 2503.
[Abstract] [Full Text] [PDF]


Home page
Arch Intern MedHome page
C. C. Peng, P. A. Glassman, L. E. Trilli, J. Hayes-Hunter, and C. B. Good
Incidence and Severity of Potential Drug-Dietary Supplement Interactions in Primary Care Patients: An Exploratory Study of 2 Outpatient Practices
Arch Intern Med, March 22, 2004; 164(6): 630 - 636.
[Abstract] [Full Text] [PDF]


Home page
The Annals of PharmacotherapyHome page
P. Kruth, E. Brosi, R. Fux, K. Morike, and C. H Gleiter
Ginger-Associated Overanticoagulation by Phenprocoumon
Ann. Pharmacother., February 1, 2004; 38(2): 257 - 260.
[Abstract] [Full Text] [PDF]


Home page
The Annals of PharmacotherapyHome page
C. Pharand, M. L Ackman, C. A Jackevicius, F. L Paradiso-Hardy, and G. J Pearson
Use of OTC and Herbal Products in Patients with Cardiovascular Disease
Ann. Pharmacother., June 1, 2003; 37(6): 899 - 904.
[Abstract] [Full Text] [PDF]


Home page
Integr Cancer TherHome page
Y. S. Chang, E.-K. Seo, C. Gyllenhaal, and K. I. Block
Panax ginseng: Panax ginseng: A Role in Cancer Therapy?
Integr Cancer Ther, March 1, 2003; 2(1): 13 - 33.
[Abstract] [PDF]


Home page
The Annals of PharmacotherapyHome page
L. Davydov, M. Yermolnik, and L. J Cuni
Warfarin and Amoxicillin/Clavulanate Drug Interaction
Ann. Pharmacother., March 1, 2003; 37(3): 367 - 370.
[Abstract] [Full Text] [PDF]


Home page
Vasc MedHome page
A. H Muir, R. Robb, M. McLaren, F. Daly, and J. J. Belch
The use of Ginkgo biloba in Raynaud's disease: a double-blind placebo-controlled trial
Vascular Medicine, November 1, 2002; 7(4): 265 - 267.
[Abstract] [PDF]


Home page
J Am Coll CardiolHome page
G. Valli and E.-G. V. Giardina
Benefits, adverse effects and drug interactionsof herbal therapies with cardiovascular effects
J. Am. Coll. Cardiol., April 3, 2002; 39(7): 1083 - 1095.
[Abstract] [Full Text] [PDF]




homecopy help contact us subscription past issues search current issue
Copyright © 2000 by Harvey Whitney Books Company.